Register to join our Biopharmaceutical Symposium — Transforming Canada’s biomanufacturing market.

There’s an exciting future for biopharmaceutical processing and manufacturing in Canada. Will you be a part of it?

Learn from industry experts and network with your peers at our upcoming Biopharmaceutical Symposium hosted by 3M Canada in collaboration with Life Sciences Ontario and Ontario Bioscience Innovation Organization (OBIO). Join us in the heart of Toronto’s Discovery District for educational exploration and opportunity to make new connections.

November 9, 2022
MaRS Centre - Auditorium
101 College St, Toronto, ON M5G 1L7, Canada

Special Guests:

• Penny Wise, VP and Managing Director, 3M Canada
• Maura Campbell, President & CEO, Ontario Bioscience Innovation Organization
• Jason Field, President & CEO, Life Science Ontario

Speakers:

Challenges in Launching a Novel Autologous Cell Therapy

1. • Chantal Martin, Senior Director, Technical Operations at Turnstone Biologics

The Importance of Production Efficiency in Upstream Processes in Biomanufacturing

1. • Ella Korets-Smith, Chief Business Officer at virica biotech

Clarification of Mammalian Cell Culture Feed Streams Using Depth and Chromatographic Filters: A Case Study

1. • Ramtin Rahbar, Senior Manager; Upstream Processing at Resilience Biotechnologies

From COVID-19 To Pandemic Preparedness

1. • J. Mark Lievonen, Co-Chair, Canada’s COVID-19 Vaccine Task Force

Launching commercial CGT-focused biomanufacturing in Canada

1. • Mitchel Sivilotti, CEO, OmniaBio

Biomanufacturing in an Academic Setting

1. • John Bell, Senior Cancer Researcher, Co-founder and Chief Scientific Officer, Ottawa Hospital Research Institute, of Jennerex, Inc.

High-resolution biological separations using membrane chromatography

1. • Raja Ghosh, Professor, McMaster

Enabling Process Compression Through Chromatographic Clarification for High Titer Cell Culture Reactors

1. • Karthik Krishnan, Technical Specialist I Single Use Technology, Thermo Fisher Scientific & David Chau, Biopharma Application Specialist, 3M

Challenges in Launching a Novel Autologous Cell Therapy.

• • • Chantal Martin, Senior Director, Technical Operations, Turnstone Biologics

Speakers and topics are still being developed, subject to change.
9:00 am - Registration and Coffee
9:30 am - Welcome
10:00 am - Speaker Presentations
12:00 pm - Complimentary Lunch
12:15 pm - Panel Discussion
1:00 pm - Speaker Presentations
4:30 pm - Closing Remarks

Space is limited — register today!
Lunch included. Registration is complimentary.

Limited to biopharmaceutical companies involved in the research, process development, and manufacturing of biological drugs.